233 related articles for article (PubMed ID: 36618379)
1. CARMA3: A potential therapeutic target in non-cancer diseases.
Gui Z; Zhang Y; Zhang A; Xia W; Jia Z
Front Immunol; 2022; 13():1057980. PubMed ID: 36618379
[TBL] [Abstract][Full Text] [Related]
2. CARMA3 Is a Critical Mediator of G Protein-Coupled Receptor and Receptor Tyrosine Kinase-Driven Solid Tumor Pathogenesis.
McAuley JR; Freeman TJ; Ekambaram P; Lucas PC; McAllister-Lucas LM
Front Immunol; 2018; 9():1887. PubMed ID: 30158935
[TBL] [Abstract][Full Text] [Related]
3. Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome.
Delekta PC; Apel IJ; Gu S; Siu K; Hattori Y; McAllister-Lucas LM; Lucas PC
J Biol Chem; 2010 Dec; 285(53):41432-42. PubMed ID: 21041303
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent.
Borthakur A; Bhattacharyya S; Alrefai WA; Tobacman JK; Ramaswamy K; Dudeja PK
Inflamm Bowel Dis; 2010 Apr; 16(4):593-603. PubMed ID: 19714753
[TBL] [Abstract][Full Text] [Related]
5. The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis.
McAllister-Lucas LM; Jin X; Gu S; Siu K; McDonnell S; Ruland J; Delekta PC; Van Beek M; Lucas PC
J Biol Chem; 2010 Aug; 285(34):25880-4. PubMed ID: 20605784
[TBL] [Abstract][Full Text] [Related]
6. CARMA3: Scaffold Protein Involved in NF-κB Signaling.
Zhang S; Lin X
Front Immunol; 2019; 10():176. PubMed ID: 30814996
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.
Howes A; O'Sullivan PA; Breyer F; Ghose A; Cao L; Krappmann D; Bowcock AM; Ley SC
Biochem J; 2016 Jun; 473(12):1759-68. PubMed ID: 27071417
[TBL] [Abstract][Full Text] [Related]
8. Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.
Knies N; Alankus B; Weilemann A; Tzankov A; Brunner K; Ruff T; Kremer M; Keller UB; Lenz G; Ruland J
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7230-8. PubMed ID: 26668357
[TBL] [Abstract][Full Text] [Related]
9. Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling.
Yang YK; Yang C; Chan W; Wang Z; Deibel KE; Pomerantz JL
J Biol Chem; 2016 Dec; 291(50):25921-25936. PubMed ID: 27777308
[TBL] [Abstract][Full Text] [Related]
10. Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity.
Pérez de Diego R; Sánchez-Ramón S; López-Collazo E; Martínez-Barricarte R; Cubillos-Zapata C; Ferreira Cerdán A; Casanova JL; Puel A
J Allergy Clin Immunol; 2015 Nov; 136(5):1139-49. PubMed ID: 26277595
[TBL] [Abstract][Full Text] [Related]
11. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.
McCully RR; Pomerantz JL
Mol Cell Biol; 2008 Sep; 28(18):5668-86. PubMed ID: 18625728
[TBL] [Abstract][Full Text] [Related]
12. CARMA3: A novel scaffold protein in regulation of NF-κB activation and diseases.
Sun J
World J Biol Chem; 2010 Dec; 1(12):353-61. PubMed ID: 21537470
[TBL] [Abstract][Full Text] [Related]
13. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex.
Martin D; Galisteo R; Gutkind JS
J Biol Chem; 2009 Mar; 284(10):6038-42. PubMed ID: 19112107
[TBL] [Abstract][Full Text] [Related]
14. Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production.
Gross O; Grupp C; Steinberg C; Zimmermann S; Strasser D; Hannesschläger N; Reindl W; Jonsson H; Huo H; Littman DR; Peschel C; Yokoyama WM; Krug A; Ruland J
Blood; 2008 Sep; 112(6):2421-8. PubMed ID: 18192506
[TBL] [Abstract][Full Text] [Related]
15. Bcl10 links saturated fat overnutrition with hepatocellular NF-kB activation and insulin resistance.
Van Beek M; Oravecz-Wilson KI; Delekta PC; Gu S; Li X; Jin X; Apel IJ; Konkle KS; Feng Y; Teitelbaum DH; Ruland J; McAllister-Lucas LM; Lucas PC
Cell Rep; 2012 May; 1(5):444-52. PubMed ID: 22708078
[TBL] [Abstract][Full Text] [Related]
16. CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation.
Grabiner BC; Blonska M; Lin PC; You Y; Wang D; Sun J; Darnay BG; Dong C; Lin X
Genes Dev; 2007 Apr; 21(8):984-96. PubMed ID: 17438001
[TBL] [Abstract][Full Text] [Related]
17. Ancient Origin of the CARD-Coiled Coil/Bcl10/MALT1-Like Paracaspase Signaling Complex Indicates Unknown Critical Functions.
Staal J; Driege Y; Haegman M; Borghi A; Hulpiau P; Lievens L; Gul IS; Sundararaman S; Gonçalves A; Dhondt I; Pinzón JH; Braeckman BP; Technau U; Saeys Y; van Roy F; Beyaert R
Front Immunol; 2018; 9():1136. PubMed ID: 29881386
[TBL] [Abstract][Full Text] [Related]
18. CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex.
Rehman AO; Wang CY
Int J Oral Sci; 2009 Sep; 1(3):105-18. PubMed ID: 20695076
[TBL] [Abstract][Full Text] [Related]
19. Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome.
David L; Li Y; Ma J; Garner E; Zhang X; Wu H
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1499-1504. PubMed ID: 29382759
[TBL] [Abstract][Full Text] [Related]
20. T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10.
Hamilton KS; Phong B; Corey C; Cheng J; Gorentla B; Zhong X; Shiva S; Kane LP
Sci Signal; 2014 Jun; 7(329):ra55. PubMed ID: 24917592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]